Rebel’s Edge Notes

Investors remain cautious ahead of key inflation data scheduled for release later this week, including the Consumer Price Index (CPI) on Wednesday. The current yield on the benchmark 10-year Treasury bond is at 4.65%, reflecting market sentiment regarding potential Fed policy adjustments amid recent labor market weaknesses.

Prediction: 

ACHR +20%: Archer Aviation shares jumped 21.31% in early trading after the company announced it would acquire Boeing’s Wisk Aero, SkyGrid, and Insitu subsidiaries. The deal will combine capabilities in autonomy, electric vertical takeoff and landing aircraft, and unmanned aircraft systems. Financial terms were not disclosed. Archer and Boeing will also enter into a collaboration and technology-sharing arrangement, under which Boeing will retain access to Wisk’s core autonomous flight technology. As part of the transaction, Archer & Boeing  are entering into a collaboration and technology-sharing arrangement through which Boeing will retain access to the Wisk core autonomous flight technology for its current and next-generation commercial and defense aircraft. The transaction is expected to allow Boeing  to retain strategic upside through its stake in Archer and simultaneously focus current and future investments into the aerospace giant’s core businesses.

VRTX (Vertex Pharmaceuticals) — approximately +5.8%: Vertex continued to climb on residual momentum from its strong second-quarter 2026 results (reported earlier in the month), which included revenue of about $3.33 billion (up ~12% year-over-year) and a raised full-year 2026 revenue guidance to $13.1–$13.2 billion. The company also highlighted progress on its pipeline and the pending acquisition of Crinetics Pharmaceuticals (adding rare endocrine disease assets), which analysts have viewed positively. Multiple firms recently raised price targets (e.g., Truist to $565, Barclays to $617), citing durable cystic fibrosis franchise strength plus diversification into non-CF products like CASGEVY and JOURNAVX. Today’s advance reflects ongoing investor rotation into biotech/pharma names with clear growth catalysts amid a softer macro backdrop from the prior week’s weak jobs data.

NTAP (NetApp) — approximately +5.4% (early session strength carried higher): NetApp gained as a storage and data-management play tied to AI and enterprise cloud demand. Early notable gainers lists highlighted the stock among liquid option names advancing in the session. The advance fits the broader tech hardware and infrastructure theme, with investors favoring companies that enable data handling for AI training and inference. Sector rotation and positive sentiment toward enterprise IT spending supported the percentage move.

SMCI (Super Micro Computer) approximately +5.1–5.5%: Super Micro advanced on optimism around AI server demand and its substantial order backlog, with investors positioning ahead of the company’s fiscal Q4/FY2026 earnings report scheduled for Tuesday, August 11. Recent commentary has highlighted potential gross-margin improvement and large-scale AI infrastructure orders. The stock has been volatile due to prior financing/dilution concerns and other headlines, but today’s bounce reflects renewed buying in AI hardware names. High volume accompanied the move as traders anticipated positive updates on fulfillment of multi-billion-dollar commitments.